找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Esophageal Cancer; Prevention, Diagnosi Nabil F. Saba,Bassel F. El-Rayes Book 2020Latest edition Springer Nature Switzerland AG 2020 Stagin

[復(fù)制鏈接]
樓主: TRACT
21#
發(fā)表于 2025-3-25 07:14:26 | 只看該作者
Radiologic Assessment of Esophageal Cancer, different conventional anatomic modalities such as esophagograms, endoscopic ultrasound, CT, and MRI are explained. In addition, the role of PET/CT, a functional and anatomic modality, is illustrated. In this chapter, the specific role of each modality is explained for each of the pillars of stagin
22#
發(fā)表于 2025-3-25 08:38:12 | 只看該作者
23#
發(fā)表于 2025-3-25 12:41:10 | 只看該作者
24#
發(fā)表于 2025-3-25 19:44:40 | 只看該作者
25#
發(fā)表于 2025-3-25 21:34:56 | 只看該作者
26#
發(fā)表于 2025-3-26 00:25:14 | 只看該作者
27#
發(fā)表于 2025-3-26 05:36:41 | 只看該作者
28#
發(fā)表于 2025-3-26 11:36:43 | 只看該作者
Systemic Treatment for Metastatic or Recurrent Disease,ismal, where the malignancy is refractory to conventional cytotoxic chemotherapy and associated with poor prognosis. While therapeutic advances over the past several years have resulted in improved patient outcomes, the observed benefits have been modest, highlighting the need for the identification
29#
發(fā)表于 2025-3-26 14:18:45 | 只看該作者
Immunotherapy in Esophageal Cancer,es has been shown to improve outcomes in a number of solid tumors, leading to their routine use in clinical practice. Early phase evaluation of immune checkpoint inhibitors demonstrated encouraging results in esophageal cancer, and studies in the chemorefractory setting have confirmed the activity o
30#
發(fā)表于 2025-3-26 20:32:06 | 只看該作者
Palliative Approaches in Esophageal Cancer,ophageal cancer remains a devastating disease in the world. Early diagnosis is difficult, since dysphagia, the common presentation symptom, occurs in late stage of the disease. When diagnosed, many patients miss the opportunity for surgical therapy. Also, patients with esophageal cancer are usually
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-15 22:03
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
南靖县| 乃东县| 新疆| 闻喜县| 绍兴县| 昌乐县| 含山县| 和林格尔县| 陈巴尔虎旗| 南平市| 北川| 台北市| 和静县| 门源| 隆回县| 都江堰市| 商河县| 浦东新区| 奉贤区| 台山市| 应城市| 巴塘县| 无为县| 余庆县| 洮南市| 乐都县| 靖西县| 凌海市| 新田县| 密山市| 四会市| 南木林县| 阳新县| 新竹县| 墨江| 永清县| 红桥区| 饶河县| 托克托县| 高淳县| 南宫市|